Nordicus Partners Corp financial data

Symbol
NORD on OTC
Industry
Services-Management Consulting Services
Location
280 South Beverly Dr., Suite 505, Beverly Hills, CA
State of incorporation
DE
Fiscal year end
March 31
Former names
EKIMAS Corp (to 5/3/2023), AdvanSource Biomaterials Corp (to 4/3/2020), CARDIOTECH INTERNATIONAL INC (to 9/8/2008)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 93.5 % +15.8%
Debt-to-equity 0.72 % -79.3%
Return On Equity -8.54 % +97.8%
Return On Assets -8.13 % +97.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.2M shares +58%
Common Stock, Shares, Outstanding 4.97M shares
Entity Public Float 5.59M USD +765%
Common Stock, Value, Issued 4.97K USD -54.3%
Weighted Average Number of Shares Outstanding, Basic 4.96M shares +357%
Weighted Average Number of Shares Outstanding, Diluted 4.96M shares +357%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.5K USD
Research and Development Expense 343K USD
General and Administrative Expense 144K USD -5.48%
Operating Income (Loss) -925K USD +73.9%
Nonoperating Income (Expense) -1.91K USD -134%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -925K USD +73.8%
Net Income (Loss) Attributable to Parent -918K USD +74%
Earnings Per Share, Basic -0.05 USD/shares +91.9%
Earnings Per Share, Diluted -0.05 USD/shares +91.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 38.8K USD +676%
Assets, Current 118K USD +1000%
Intangible Assets, Net (Excluding Goodwill) 223K USD
Goodwill 18.6M USD
Other Assets, Noncurrent 318K USD +11931%
Assets 20.8M USD +1077%
Contract with Customer, Liability, Current 7.5K USD
Liabilities, Current 153K USD +495%
Liabilities 153K USD +495%
Accumulated Other Comprehensive Income (Loss), Net of Tax 13.7K USD
Retained Earnings (Accumulated Deficit) -44.6M USD -5.45%
Stockholders' Equity Attributable to Parent 19.7M USD +1031%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 27.7K USD
Liabilities and Equity 20.8M USD +1077%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -218K USD
Net Cash Provided by (Used in) Financing Activities 60K USD +140%
Net Cash Provided by (Used in) Investing Activities 135K USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 4.97M shares -54.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -60K USD +24.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 46.1K USD +328%
Deferred Tax Assets, Valuation Allowance 2.38M USD +2.69%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.27 pure 0%
Deferred Tax Assets, Gross 3.18M USD +9.91%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -902K USD +74.5%
Deferred Tax Assets, Operating Loss Carryforwards 2.38M USD +2.69%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 64.3M USD +46%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.18M USD +9.91%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%